The manufacturing costs of most peptides can be significantly reduced by applying our proprietary biotechnology. Whilst most peptides are today produced by chemical synthesis, competitive platform technologies for recombinant production have not been available so far. But NUMAFERM now offers a technology that allows plannable production of any peptide with high yields and high purity levels. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters. At the same time, peptides now become available for entirely new fields, such as technical applications like special adhesives or functional coatings.
NUMAFERM is your expert for the establishment of cost-efficient peptide supply in bulk quantities and as a supplier for long or hard-to-produce peptides. Our patented platform technology utilizes E. coli bacteria and is based on state-of-the-art fermentative bioprocess.